Search Results 671-680 of 3779 for Liquefaction
Phase 2a, Dose-ranging Study With PF-05221304 In Nonalcoholic Fatty Liver Disease (NAFLD) · Overview · Participation eligibility · Participating Mayo Clinic ...
This condition can come on suddenly or develop over time. Find out more about symptoms and treatment for this condition that restricts blood flow to the ...
Learn what to expect before and after this important treatment option for people with liver failure.
The purpose of this study is to measure the number of calories delivered from fluids used in continuous renal replacement therapy. This could help better ...
Mayo researchers were among the first to identify nonalcoholic fatty liver disease and primary sclerosing cholangitis. Mayo researchers also are making ...
The purpose of this study is to evaluate the pharmacokinetics, pharmacodynamics, safety and tolerability of multiple doses of lixivaptan in Autosomal Dominant ...
Mayo Clinic's Division of Gastroenterology and Hepatology offers treatment and specialty care for people with a wide range of rare and common digestive ...
Robotic systems can help surgeons increase precision, flexibility and control for many procedures. Learn about the advantages and availability of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!